Greenwich LifeSciences ( (GLSI) ) has released a notification of late filing.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Greenwich LifeSciences, Inc. has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending March 31, 2025. The company cites the need for additional time to complete the report without incurring unreasonable effort or expense as the primary reason for the delay. The company has committed to filing the report by May 20, 2025, within the five-day extension period allowed under SEC rules. Importantly, Greenwich LifeSciences does not anticipate any significant changes in its financial results compared to the same period last year. The notification has been signed by Snehal Patel, the Chief Executive Officer, indicating ongoing compliance efforts.
The most recent analyst rating on (GLSI) stock is a Buy with a $36.00 price target. To see the full list of analyst forecasts on Greenwich LifeSciences stock, see the GLSI Stock Forecast page.
More about Greenwich LifeSciences
Average Trading Volume: 74,476
Technical Sentiment Signal: Strong Sell
Current Market Cap: $128.6M
For a thorough assessment of GLSI stock, go to TipRanks’ Stock Analysis page.